147 related articles for article (PubMed ID: 10483686)
21. European experience on the practical use of levosimendan in patients with acute heart failure syndromes.
Follath F; Franco F; Cardoso JS
Am J Cardiol; 2005 Sep; 96(6A):80G-5G. PubMed ID: 16181827
[TBL] [Abstract][Full Text] [Related]
22. [Push of inotropic drugs in the treatment of refractory chronic cardiac insufficiency].
Martínez Martínez JA; Salvati A; Suárez LD
Medicina (B Aires); 1986; 46(3):363-4. PubMed ID: 3574096
[No Abstract] [Full Text] [Related]
23. Hawthorn--Crataegus monogyna (common hawthorn) or Crataegus laevigata (midland hawthorn; Crataegus oxyacantha); also known as haw, thornapple, maythorn, whitethorn.
Rasmussen P
J Prim Health Care; 2011 Mar; 3(1):63-4. PubMed ID: 21359265
[No Abstract] [Full Text] [Related]
24. Beta-blocking agents and positive inotropic agents in the therapy of chronic heart failure.
Erdmann E; Schwinger R; Böhm M
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S138-44. PubMed ID: 11527118
[TBL] [Abstract][Full Text] [Related]
25. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
Dieterich HA; Wendt C; Saborowski F
Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159
[TBL] [Abstract][Full Text] [Related]
26. [Crataegus Special Extract WS 1442 in NYHA II heart failure. A placebo controlled randomized double-blind study].
Leuchtgens H
Fortschr Med; 1993 Jul; 111(20-21):352-4. PubMed ID: 8375791
[TBL] [Abstract][Full Text] [Related]
27. [Therapy of heart failure in the elderly].
Zobel C; Schwinger RH
Med Klin (Munich); 2006 Mar; 101 Suppl 1():47-50. PubMed ID: 16802519
[TBL] [Abstract][Full Text] [Related]
28. [Protocol-guide in clinical experimentation on inotropic drugs].
Campolo L; Padrini R; Razzolini R; Klugmann S; Chioin R
G Ital Cardiol; 1985 Jul; 15(7):695-9. PubMed ID: 4076703
[No Abstract] [Full Text] [Related]
29. Inotropic therapy for heart failure: an evidence-based approach.
Felker GM; O'Connor CM
Am Heart J; 2001 Sep; 142(3):393-401. PubMed ID: 11526351
[TBL] [Abstract][Full Text] [Related]
30. Benefit-Risk Assessment of Crataegus Extract WS 1442: An Evidence-Based Review.
Holubarsch CJF; Colucci WS; Eha J
Am J Cardiovasc Drugs; 2018 Feb; 18(1):25-36. PubMed ID: 29080984
[TBL] [Abstract][Full Text] [Related]
31. Newer approaches to the pharmacological management of heart failure.
Rauch H; Motsch J; Böttiger BW
Curr Opin Anaesthesiol; 2006 Feb; 19(1):75-81. PubMed ID: 16547437
[TBL] [Abstract][Full Text] [Related]
32. [Crataegus Special Extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II)].
Weikl A; Assmus KD; Neukum-Schmidt A; Schmitz J; Zapfe G; Noh HS; Siegrist J
Fortschr Med; 1996 Aug; 114(24):291-6. PubMed ID: 8974970
[TBL] [Abstract][Full Text] [Related]
33. Beneficial effects of the extract from Corydalis yanhusuo in rats with heart failure following myocardial infarction.
Wu L; Ling H; Li L; Jiang L; He M
J Pharm Pharmacol; 2007 May; 59(5):695-701. PubMed ID: 17524235
[TBL] [Abstract][Full Text] [Related]
34. Overview of randomized clinical trials in acute heart failure syndromes.
Teerlink JR
Am J Cardiol; 2005 Sep; 96(6A):59G-67G. PubMed ID: 16181824
[TBL] [Abstract][Full Text] [Related]
35. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
[TBL] [Abstract][Full Text] [Related]
36. Herbal treatment for cardiovascular disease the evidence based therapy.
Mahmood ZA; Sualeh M; Mahmood SB; Karim MA
Pak J Pharm Sci; 2010 Jan; 23(1):119-24. PubMed ID: 20067878
[TBL] [Abstract][Full Text] [Related]
37. Crataegus special extract WS 1442 improves cardiac function and reduces infarct size in a rat model of prolonged coronary ischemia and reperfusion.
Veveris M; Koch E; Chatterjee SS
Life Sci; 2004 Feb; 74(15):1945-55. PubMed ID: 14761675
[TBL] [Abstract][Full Text] [Related]
38. Survival and prognosis: investigation of Crataegus extract WS 1442 in congestive heart failure (SPICE)--rationale, study design and study protocol.
Holubarsch CJ; Colucci WS; Meinertz T; Gaus W; Tendera M
Eur J Heart Fail; 2000 Dec; 2(4):431-7. PubMed ID: 11113721
[TBL] [Abstract][Full Text] [Related]
39. Hemodynamic properties of a new-generation positive luso-inotropic agent for the acute treatment of advanced heart failure.
Sabbah HN; Imai M; Cowart D; Amato A; Carminati P; Gheorghiade M
Am J Cardiol; 2007 Jan; 99(2A):41A-46A. PubMed ID: 17239704
[TBL] [Abstract][Full Text] [Related]
40. Levosimendan: beyond its simple inotropic effect in heart failure.
Antoniades C; Tousoulis D; Koumallos N; Marinou K; Stefanadis C
Pharmacol Ther; 2007 May; 114(2):184-97. PubMed ID: 17363065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
